We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
(+1.4%)
Cap. Flow
-$1.3B
Cap. Flow
% of AUM
-5.9%
Top 10 Holdings %
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$148M |
| 2 |
Netflix
NFLX
|
+$119M |
| 3 |
Airbnb
ABNB
|
+$111M |
| 4 |
XYZ
Block Inc
XYZ
|
+$89.5M |
| 5 |
Danaher
DHR
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$212M |
| 2 |
Alibaba
BABA
|
+$172M |
| 3 |
Zoetis
ZTS
|
+$133M |
| 4 |
TransUnion
TRU
|
+$124M |
| 5 |
Baidu
BIDU
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.88% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 12.06% |
| 4 | Technology | 11.2% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFC
751
Ellington Financial
EFC
$1.68B
| $5.85M | 0.03% |
+305,614
| New | +$5.65M |
|
752
iShares MSCI Emerging Markets ETF
EEM
$28B
| $5.83M | 0.03% |
+105,743
| New | +$5.75M |
|
|
GETR
753
DELISTED
Getaround, Inc.
GETR
| $5.82M | 0.03% |
+599,960
| New | +$5.86M |
|
754
Legend Biotech
LEGN
$4.3B
| $5.8M | 0.03% |
141,375
+117,753
| +498% | +$4M |
|
|
BGSX
755
DELISTED
Build Acquisition Corp.
BGSX
| $5.8M | 0.03% |
+599,988
| New | +$5.8M |
|
756
TechnipFMC
FTI
$30.6B
| $5.8M | 0.03% |
645,037
-72,998
| -10% | -$617K |
|
757
LG Display
LPL
$3.17B
| $5.78M | 0.03% |
540,973
+104,937
| +24% | +$1.12M |
|
|
OPA
758
DELISTED
Magnum Opus Acquisition Limited
OPA
| $5.77M | 0.03% |
+599,992
| New | +$5.82M |
|
|
GLHA
759
DELISTED
Glass Houses Acquisition Corp. Class A common stock
GLHA
| $5.77M | 0.03% |
+599,992
| New | +$5.79M |
|
760
Sable Offshore Corp
SOC
$903M
| $5.77M | 0.03% |
+597,390
| New | +$5.78M |
|
761
UnitedHealth
UNH
$382B
| $5.76M | 0.03% |
14,387
-17,348
| -55% | -$6.92M |
|
762
iShares US Transportation ETF
IYT
$2.33B
| $5.75M | 0.03% |
+88,552
| New | +$5.92M |
|
763
Buckle
BKE
$2.19B
| $5.75M | 0.03% |
115,586
-40,413
| -26% | -$1.72M |
|
764
Super League Enterprise
SLE
$4.28M
| $5.75M | 0.03% |
111
+12
| +12% | +$615K |
|
765
Restaurant Brands International
QSR
$25.1B
| $5.75M | 0.03% |
89,128
+49,385
| +124% | +$3.33M |
|
|
SHOE
766
Shoe Station Group
SHOE
$395M
| $5.74M | 0.03% |
160,462
+120,710
| +304% | +$3.91M |
|
767
RUM Group Inc
RUM
$1.57B
| $5.73M | 0.03% |
+588,684
| New | +$5.75M |
|
|
PLXP
768
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $5.72M | 0.03% |
414,186
+148,724
| +56% | +$1.76M |
|
769
Norwegian Cruise Line
NCLH
$8.89B
| $5.68M | 0.03% |
193,015
-2,086,645
| -92% | -$62.9M |
|
770
SiteOne Landscape Supply
SITE
$4.43B
| $5.66M | 0.03% |
33,429
+25,021
| +298% | +$4.38M |
|
|
GTM
771
ZoomInfo Technologies
GTM
$861M
| $5.63M | 0.03% |
108,013
+101,291
| +1,507% | +$4.76M |
|
|
NGMS
772
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $5.62M | 0.03% |
91,466
+69,016
| +307% | +$3.6M |
|
|
HERAW
773
CALL
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
| $5.62M | 0.03% |
+575,994
| New | +$622K |
|
774
Hess Midstream
HESM
$5.22B
| $5.61M | 0.03% |
222,206
-146,981
| -40% | -$3.55M |
|
775
StepStone Group
STEP
$3.48B
| $5.61M | 0.03% |
163,033
-37,586
| -19% | -$1.25M |
|
Similar funds
Marshall Wace's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.
- Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
- Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
- Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
- Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
- Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
- Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
- Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.
Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.